FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/04/024655 [Registered on: 15/04/2020] Trial Registered Prospectively
Last Modified On: 05/04/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical research trial to find the safety and effectiveness of asgand and brahmi in underactive thyroid gland function 
Scientific Title of Study   A Randomized,Active-Controlled,Assessor-Blinded,Parallel Group Clinical Study to evaluate the safety and efficacy of Asgand and Brahmi in the Management of Qillat-e-Darqiyyat Asli (Primary Hypothyroidism) 
Trial Acronym  PGJV 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  juveria jabeen 
Designation  PG Scholar 
Affiliation  National Research Institute of Unani Medicine for Skin Disorders 
Address  National Research Institute of Unani Medicine for Skin Disorders,Erragadda,hyderabad.
National Research Institute of Unani Medicine for Skin Disorders,Erragadda,hyderabad.
Hyderabad
TELANGANA
500038
India 
Phone  8978812833  
Fax    
Email  juveriaanam@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Qamar uddin 
Designation  Professor 
Affiliation  National Research Institute of Unani Medicine for Skin Disorders 
Address  old building,1st floor room no.115
National Research Institute of Unani Medicine for Skin Disorders,Erragadda,hyderabad.
Hyderabad
TELANGANA
500038
India 
Phone  8700027178  
Fax    
Email  ccrumhqrsnd58@gmail.com  
 
Details of Contact Person
Public Query
 
Name  juveria jabeen 
Designation  PG Scholar 
Affiliation  National Research Institute of Unani Medicine for Skin Disorders 
Address  PG department moalajat,new building ground floor,male OPD room no.1
National Research Institute of Unani Medicine for Skin Disorders,Erragadda,hyderabad.
Hyderabad
TELANGANA
500038
India 
Phone  8978812833  
Fax    
Email  juveriaanam@gmail.com  
 
Source of Monetary or Material Support  
National Research Institute of Unani Medicine for Skin Disorders, AG Colony Road, Opp. ESI Hospital, Erragadda, Hyderabad-500 038  
 
Primary Sponsor  
Name  National Research Institute of Unani Medicine for Skin Disorders Hyderabad  
Address  National Research Institute of Unani Medicine for Skin Disorders Hyderabad  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
juveria jabeen  National Research Institute of Unani Medicine for Skin Disorders, Hyderabad   PG department moalajat,new building ground floor,male OPD room no.1
Hyderabad
TELANGANA 
8978812833

juveriaanam@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E039||Hypothyroidism, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Asgand and Brahmi  Asgand and Brahmi 6 gms powder twice daily orally with water after meals. 
Comparator Agent  Levothyroxine  50 mcg 2 tablets once daily orally with water before meals in morning 
 
Inclusion Criteria  
Age From  19.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients of any gender
Patients in the age group between 19 and 60 years
Patients with Symptomatic Subclinical Primary Hypothyroidism
Patients with Clinical Primary Hypothyroidism
TSH ranging 5-10mg/dl  
 
ExclusionCriteria 
Details  Patients aged <19years or >60 years
Asymptomatic cases of Subclinical Primary Hypothyroidism
Severe/ complicated cases of Clinical Primary Hypothyroidism
Patients with Drug-induced Hypothyroidism
Patients on radiotherapy for head and neck region
ï‚· Patients who have undergone thyroidectomy
ï‚· Pregnant or Lactating Women
ï‚· Significant Pulmonary/ Cardiovascular/ Hepatic/ Renal Diseases
ï‚· Known cases of Immunocompromised states (HIV/ AIDS, etc.)/ Malignancies
ï‚· Patients with Diabetes Mellitus
ï‚· Patients with history of hypersensitivity to Asgand or Brahmi ï‚· Patient not willing to attend treatment schedule regularly  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Clinical assessment will be done at 0, 2, 4 ,6 and 8 weeks and the response to treatment will be assessed using the following parameters:
1. Decrease in serum TSH level
2. Increase in serum Free T4 level
3. Improvement in the symptoms & signs of hypothyroidism as assessed by reduction in Zulewski’s clinical score after treatment  
2nd week
4th week
6th week
8th week 
 
Secondary Outcome  
Outcome  TimePoints 
Lab investigation  0 and 8 weeks 
 
Target Sample Size   Total Sample Size="45"
Sample Size from India="45" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/05/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Need for the Study

Primary hypothyroidism refers to hormone deficiency caused by intrinsic thyroid gland dysfunction that disrupts the synthesis and secretion of T4 and T3. Primary hypothyroidism is one of the most common endocrine conditions, occurring in 5% of individuals. Mild hypothyroidism is present in as many as 15% of older adults. Hypothyroidism is more common in women.

     Hypothyroidism continues to grow significantly in the country particularly among women. A survey conducted by Indian Thyroid Society depicts one in ten adults in India suffer from hypothyroidism. According to survey, the disease is more prevalent among women who are three times more likely to be affected by hypothyroidism than men especially in the age group of 46-54 years. A significant proportion of patient population may go undetected and untreated even as it continues to impair the daily quality of life, work performance and economic productivity [14].

     Thyroid hormone deficiency affects almost all body functions; and hypothyroidism if left untreated, may lead to complications such as infertility, delirium, dementia, cerebellar ataxia, seizures, psychosis (myxedema madness), confusion, myxedema coma, hypothermia, severe cardiac failure (myxedema heart), pericardial effusions, etc.

     In conventional medicine, levothyroxine is being used effectively in the management of hypothyroidism, but it can suppress the TSH to subnormal range and can cause serious side effects on bone density and cardiac function, such as osteoporosis, atrial fibrillation, myocardial ischaemia, etc. Therefore, there is a need to develop safe and effective drug for the management of Qillat-e-Darqiyyat Aá¹£li (Primary Hypothyroidism).

     In a recent survey conducted by American Thyroid Association demonstrated that patients taking natural preparations, rather than synthetic hormone replacement therapy or combination therapy, were more satisfied with their treatment [20]. Asgand (Withania somnifera) and Brahmi (Bacopa monnieri) have been used for centuries in Unani system of medicine for various ailments; and a combination of Asgand and Brahmi is being used for the management of depression, anxiety and chronic stress[22]; none of the studies have evaluated the effect of this drug combination in hypothyroidism. However, it has been shown in most of the pharmacological studies that both the drugs can stimulate the thyroid gland to produce more T4 hormone [15-17,19,23,24].

     Keeping these facts in mind, it has been decided to conduct a research work entitled “A Randomized, Active-Controlled, Assessor-Blinded, Parallel Group Clinical Study to evaluate the safety and efficacy of Asgand and Brahmi in the Management of Qillat-e-Darqiyyat Aá¹£li (Primary Hypothyroidism)”.

Review of Literature

The thyroid gland is a butterfly-shaped endocrine gland that is located in the lower front of the neck. The thyroid’s job is to make thyroid hormones, which are secreted into the blood and then carried to every tissue in the body. Thyroid hormone helps the body use energy, stay warm and keep the brain, heart, muscles, and other organs working as they should. Hypothyroidism is an underactive thyroid gland [1]. Hypothyroidism means that the thyroid gland can’t make enough thyroid hormone to keep the body running normally. When thyroid hormone levels are too low, the body’s cells can’t get enough thyroid hormone and the body’s processes start slowing down and shows the symptoms like tiredness, weakness, dry skin, feeling cold, hair loss, difficulty concentrating, poor memory, constipation, weight gain with poor appetite, dyspnoea, hoarse voice, menorrhagia (later oligomenorrhoea or amenorrhoea), paraesthesia, impaired hearing; and signs like dry coarse skin, cool peripheral extremities, puffy face, hands, and feet (myxoedema), diffuse alopecia, bradycardia, peripheral edema, delayed tendon reflex relaxation, Carpal Tunnel Syndrome, and serous cavity effusions [2].

     As such hypothyroidism has not been described in Unani classical literature, but some of the clinical features associated with this disease are very much similar to those described in the context of Su’-i-Mizāj Bārid (abnormal cold temperament). According to Unani literature, the normal temperament of the thyroid gland is hot [3], but in hypothyroidism it changes from hot to abnormal cold temperament (Su’-i-Mizāj Bārid). Some Unani scholars consider hypothyroidism as BalghmaÄ« (Phlegmatic) disease. Ghlaba-i-Balgham (domination of phlegmatic humour) is characterized by bradycardia, low volume pulse, sluggishness of skeletal muscles, puffiness, peripheral edema, cool peripheral extremities, sluggish thinking. These signs and symptoms are found in patients with hypothyroidism [4]. The signs and symptoms of Su’-i-Mizāj Bārid (abnormal cold temperament) include Khushk wa KhurdarÄ« Jild (dry and coarse skin), Shuḥūb (skin pallor), Lisān SamÄ«k (thick tongue), Fará¹­ al-Nawm (excessive sleep), Takān wa Kasalmandi (lethargy and somnolence), Nabḍ Baá¹­Ä« wa Mutafāwit (low volume pulse), Khafaqān (palpitation), Tahabbuj (puffiness of face), Kund Zahni (diminished intellectual functions), Ḍu‘f al-Shahwa (loss of libido), Ḥuá¹£r (constipation), Ḍu‘f al-Ishtiḥā’ (decreased appetite), [5-9,18,21] etc; and these features coincides with the clinical manifestations of Qillat-e-Darqiyyat (hypothyroidism). Thus, Su’-i-Mizāj Bārid including Su’-i-Mizāj BalghmaÄ« may be interpreted with the clinical presentations of Qillat-e-Darqiyyat (hypothyroidism). Although the ancient Unani physicians have described a common disorder of thyroid gland in their literature as goiter (enlargement of thyroid gland) and its treatment.

     Buqrāt (Hippocrates) (460-337 BC) narrated in context to the glands that “when glands of the neck become diseased themselves, they become tubercular and produce struma”. The term “struma” is still used in some European countries (e.g. Austria, Italy) as the medical designation of goiter.

     Ismā‘il Jurjānī’s ’Treasure of Medicine’ first associated with exophthalmos (protrusion of the eyes), we now associate it with Grave’s disease (goiter). ‘AlÄ« ibn ‘Abbās MajÅ«sÄ« (d. 994 AD) stated that the Waram which occurs due to Balgham-e-GhalÄ«z results in Ghayngha (goiter) which are similar to glands. Ibn Hubal BaghdādÄ« (1121-1213 AD) mentioned exophthalmic goiter under the heading Juḥūẓ al-‘Ayn (exophthalmos) in his book, “Kitāb al-Mukhtārāt fi’l Ṭibb”. He narrated as: “The main cause of Juḥūẓ al-‘Ayn is accumulation of matter. The matter may be liquid or gaseous in nature. These matters accumulate in the vessels of the eyes result in dilatation of the vessels. Collectively we can say that increased pressure of vessels of eyes is the cause of disease”.

     According to Ibn SÄ«nā (Avicenna), the signs of phlegm being predominant are excessive pallor, flabbiness of body, cold and moist skin, excessive salivation and viscid saliva. Thirst is diminished especially in elderly persons except of course when the acid phlegm predominates. A weak digestion with acid eructation, pale urine, excessive sleepiness, flabby muscles, mental dullness and a soft pulse of slow rate and speed are characteristics of this condition. According to this, the line of treatment when a temperamental abnormality is simple, i.e., without any complicating factor, its treatment is counteraction [7].

 
Close